MARKET

VCYT

VCYT

Veracyte
NASDAQ
60.49
+1.94
+3.31%
After Hours: 60.37 -0.12 -0.20% 19:58 06/26 EDT
OPEN
58.55
PREV CLOSE
58.55
HIGH
60.83
LOW
58.06
VOLUME
3.33M
TURNOVER
--
52 WEEK HIGH
60.83
52 WEEK LOW
22.61
MARKET CAP
4.83B
P/E (TTM)
56.02
1D
5D
1M
3M
1Y
5Y
1D
What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally
NASDAQ · 1d ago
The Disinflation Trade Has A New Address: Genomics
Seeking Alpha · 2d ago
As AbbVie eyes Apogee, these biotech stocks earn the highest Quant ratings
Seeking Alpha · 6d ago
Cathie Wood's Ark Invest weekly recap: Block and Snowflake bought, Roku and Strata liquidated
Seeking Alpha · 6d ago
Weekly Report: what happened at VCYT last week (0615-0619)?
Weekly Report · 6d ago
TSLA, AMZN, PLTR, RKLB, and More: Cathie Wood Takes Profits Across Tech in All-Sell Session — 6/16/26
TipRanks · 06/16 09:10
Cathie Wood's weekly recap: sells Tesla, AMD, HOOD, TER to fund SpaceX buying
Seeking Alpha · 06/15 11:02
Weekly Report: what happened at VCYT last week (0608-0612)?
Weekly Report · 06/15 10:36
More
About VCYT
Veracyte, Inc. is a global diagnostics company. It enables clinicians with insights they need to guide and assure patients. The Company offers tests for thyroid cancer (Afirma), prostate cancer (Decipher Prostate), breast cancer (Prosigna), interstitial lung diseases (Envisia), and bladder cancer (Decipher Bladder). Its Percepta Nasal Swab test is being run in its Clinical Laboratory Improvement Amendments (CLIA) lab in support of clinical studies and its tests for kidney cancer and lymphoma are in development, the latter as a companion diagnostic. Its products consist of the Prosigna breast cancer assay, the nCounter Analysis System, related diagnostic kits, and services. In the United States, it offers laboratory developed tests (LDTs), through its CLIA laboratories in South San Francisco and San Diego, California, supported by its cytopathology know-how in Austin, Texas. The Company also offers whole-genome MRD platform that enable it in early cancer diagnosis and risk assessment.

Webull offers Veracyte Inc stock information, including NASDAQ: VCYT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCYT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VCYT stock methods without spending real money on the virtual paper trading platform.